BlueView

During the last three years, the primary focus in the vaccine market has been the development, distribution, and administration of COVID-19 vaccines. Since December 2020, more than 13.2 billion vaccine doses have been administered. Roughly 70 percent of the global population...

Specialty pharmacy represents the largest single-focus opportunity for health systems to improve patient outcomes and experiences while still realizing incremental economic growth. 

Through 2025, the specialty drug market is expected to grow by 8 percent a year, which...

One of the primary vaccine administration programs designed to increase access and uptake of vaccines is the entitlement program Vaccines for Children (VFC).

The VFC program was launched after a measles outbreak in the early 1990s, when it was determined more than half of the...

As of January 2023, there are 230 entries on the ASHP’s Current Drug Shortage Bulletin. While drug shortages are not a new phenomenon, visibility into current shortages is increased because of the drugs on the list and the populations most directly impacted.

It’s been nearly three years since the first confirmed case of COVID-19 in the United States. Since then, the country has seen nearly one hundred million confirmed cases and more than one million fatalities due to the virus.

Since the implementation of COVID-19 vaccines in...

As we approach the end of the year, the Helmer Scientific team took an opportunity to look back at the blogs from this year. We have compiled a list of the top 10 pharmacy and vaccine-related posts from 2022.

Topics include updated regulatory requirements, ongoing support for...

Pharmacists who carry out sterile compounding are no strangers to the stringent garbing and sterilization requirements required by USP General Chapter <797>. While USP <797> is the universally accepted guideline for cleanroom garbing requirements, state pharmacy board...

The first COVID-19 vaccine, the Pfizer-BioNTech COVID-19 vaccine, was approved for emergency use on December 11, 2020, in adults 16 and older.

Since the first emergency use authorization was issued, the FDA has authorized the use of vaccines from three additional...

Pharmacy Purchasing & Products (PP&P) published the results of its 17thAnnual State of Pharmacy Automation Survey. This survey is based on data provided by 363 pharmacy leaders across a wide range of facility type, size, and location.

Since initially approved for emergency use in late 2020, COVID-19 vaccinations have proven to be the best weapon in the fight against COVID-19. Since the pandemic began, there have been nearly 95 million COVID-19 cases in the United States.